NEW YORK (GenomeWeb News) – NextBio and Genophen today said they are partnering to drive adoption of genomics for disease prevention and wellness.

They said the deal allows Genophen to interpret genomic sequencing data from patients through the use of NextBio's clinical platform and to combine this information with data about a patient's environmental, behavioral, and clinical factors "to create a uniquely tailored disease prevention and wellness plan for its individual member."

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.